Your browser doesn't support javascript.
loading
Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis.
Lee, Brian P; Roth, Nitzan; Rao, Prathik; Im, Gene Y; Vogel, Alexander S; Hasbun, Johann; Roth, Yoel; Shenoy, Akhil; Arvelakis, Antonios; Ford, Laura; Dawe, Inga; Schiano, Thomas D; Davis, Jordan P; Rice, John P; Eswaran, Sheila; Weinberg, Ethan; Han, Hyosun; Hsu, Christine; Fix, Oren K; Maddur, Haripriya; Ghobrial, R Mark; Therapondos, George; Dilkina, Bistra; Terrault, Norah A.
Afiliação
  • Lee BP; University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Roth N; Northwell Health, New York City, New York, USA.
  • Rao P; University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Im GY; Mount Sinai Icahn School of Medicine, New York City, New York, USA.
  • Vogel AS; Harvard Medical School, Boston, Massachusetts, USA.
  • Hasbun J; New York University Grossman School of Medicine, New York City, New York, USA.
  • Roth Y; Twitter Inc, San Francisco, California, USA.
  • Shenoy A; Columbia University Vagelos College of Physicians and Surgeons, New York City, New York, USA.
  • Arvelakis A; Mount Sinai Icahn School of Medicine, New York City, New York, USA.
  • Ford L; Mount Sinai Icahn School of Medicine, New York City, New York, USA.
  • Dawe I; Mount Sinai Icahn School of Medicine, New York City, New York, USA.
  • Schiano TD; Mount Sinai Icahn School of Medicine, New York City, New York, USA.
  • Davis JP; University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Rice JP; University of Wisconsin, Madison, Wisconsin, USA.
  • Eswaran S; Rush Medical Center, Chicago, Illinois, USA.
  • Weinberg E; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Han H; University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Hsu C; Georgetown School of Medicine, Washington, District of Columbia, USA.
  • Fix OK; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Maddur H; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Ghobrial RM; Houston Methodist Hospital, Houston, Texas, USA.
  • Therapondos G; Ochsner Clinic, New Orleans, Louisiana, USA.
  • Dilkina B; University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Terrault NA; University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Am J Transplant ; 22(7): 1834-1841, 2022 07.
Article em En | MEDLINE | ID: mdl-35416409
ABSTRACT
Early liver transplantation (LT) for alcohol-associated hepatitis (AH) is the fastest growing indication for LT, but prediction of harmful alcohol use post-LT remains limited. Among 10 ACCELERATE-AH centers, we examined psychosocial evaluations from consecutive LT recipients for AH from 2006 to 2017. A multidisciplinary panel used content analysis to develop a maximal list of psychosocial variables. We developed an artificial intelligence model to predict post-LT harmful alcohol use. The cohort included training (N = 91 among 8 centers) and external validation (N = 25 among 2 centers) sets, with median follow-up of 4.4 (IQR 3.0-6.0) years post-LT. In the training set, AUC was 0.930 (95%CI 0.862-0.998) with positive predictive value of 0.891 (95%CI 0.620-1.000), internally validated through fivefold cross-validation. In the external validation set, AUC was 0.692 (95%CI 0.666-0.718) with positive predictive value of 0.82 (95%CI 0.625-1.000). The model identified specific variables related to social support and substance use as highly important to predict post-LT harmful alcohol use. We retrospectively developed and validated a model that identified psychosocial profiles at LT predicting harmful alcohol use post-LT for AH. This preliminary model may inform selection and post-LT management for AH and warrants prospective evaluation in larger studies among all alcohol-associated liver disease being considered for early LT.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Alcoolismo / Hepatite Alcoólica / Hepatopatias Alcoólicas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Alcoolismo / Hepatite Alcoólica / Hepatopatias Alcoólicas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article